Publikationsdienste
→
Auflistung nach Autor

Auflistung nach Autor "Huober, Jens"

Anzeige der Dokumente 1-7 von 7

Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group

Huober, Jens (2013)
Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2-early breast cancer: WSG-AGO EC-Doc Trial

Huober, Jens; Wallwiener, Diethelm (2016)
Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression

Huober, Jens; Wallwiener, Diethelm (2014)
Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - Results of the eLEcTRA trial

Huober, Jens; Wallwiener, Diethelm (2012)
Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial

Huober, Jens (2015)
Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV

Huober, Jens (2012)
Response-Guided Neoadjuvant Chemotherapy for Breast Cancer

Huober, Jens (2013)

Anzeige der Dokumente 1-7 von 7

Veröffentlichen

Stöbern

Gesamter Bestand

Mein Benutzerkonto

Einloggen

Hilfe & Infos